• Community pharmacy contract funding frozen at £2.59bn for next five years

    Community pharmacies in England are set to receive £13bn over the next five years under a newly-agreed contract, with a planned spend of £2.59bn each year.

    This represents a freeze in the community pharmacy funding package, with a £2.59bn annual funding pot also agreed during negotiations in 2018.

    The community pharmacy framework contract, published jointly by the Department of Health and Social Care (DHSC), NHS England and the Pharmaceutical Services Negotiating Committee (PSNC), also revealed that medicines use reviews (MURs) will be phased out over the next two years, with the number of MURs community pharmacies can each carry out to be capped at 250 in 2019/2020 and 100 in 2020/2021.

    Instead, so-called “clinical pharmacists” will take on “structured medicines reviews” in primary care networks (PCNs).

    The new contract also details plans to phase out establishment payments, paid to all pharmacies that dispense a certain number of presciptions annually, from the £164m paid in 2018/2019 to £123m in 2019/2020, with no funding thereafter.

    The £94m currently spent on MURs and the establishment payment funding will be reinvested into new initiatives set out in the contract, including the Community Pharmacy Consultation Service (CPCS), which NHS England says will launch in October 2019.

    The CPCS, which will combine the Digital Minor Illness Referral Service and the NHS Urgent Medicine Supply Advanced Service into one service, will see pharmacists receive £14 per consultation. Overall funding for the CPCS will increase from £4m in 2019/2020 to £19m in 2023/2024.

    Pharmacists will also receive £5.35 for each item supplied under the serious shortage protocols, which came into force in July 2019.

    The funding breakdown also includes “unallocated funding for future clinical services to include transition payments”, and the PSNC said there were also plans to launch pilot projects in 2019/2020 to implement point-of-care testing in pharmacies to support efforts to tackle antimicrobial resistance, as well as a smoking cessation referrals pilot from secondary care services.

    Commenting on the contract, Simon Dukes, chief executive of the PSNC, said: “Over the past four months, the PSNC has put a considerable amount of data [to the Department of Health and Social Care, NHS England and NHS Improvement] to demonstrate the rising cost base of the sector, as well as continually highlighting the value of pharmacy services, in order to try and persuade government to reverse that planned downwards trajectory of pharmacy funding.

    “While we have not succeeded in getting an increase in the overall sum, we have secured a commitment from the government to a protected £13bn over five years.”


  • pause slideshow

Pharmacist scanning medicines packet

MHRA has taken action against companies on FMD compliance

The Medicines and Healthcare Regulatory Agency has confirmed that it has taken regulatory action against a small number of companies for infringements relating to compliance with the Falsified Medicines Directive.

NHS prescription

Pharmacists’ medicines recommendations not being actioned by GPs, study finds

More than half of recommendations from pharmacists advising changes to prescriptions were not actioned by GPs in the practice, a study has found.

More news

Statin tablets

Statin treatment associated with reduced risk of glaucomaSubscription

Receiving statin treatment for five years or more is associated with a 21% reduced risk of primary glaucoma, research has shown.

Kidney ultrasound

SGLT2 inhibitor lowers risk of kidney failure in type 2 diabetesSubscription

Patients with type 2 diabetes mellitus and chronic kidney disease have a lower risk of kidney failure and cardiovascular events if they are treated with canagliflozin, research has confirmed.

Older person using smartphone

App helps patients cut opioid use after knee replacementSubscription

Patients who underwent knee replacement who used an app to monitor their analgesic use had better pain control and took fewer opioids post surgery, study results show.


Concerns raised over non-medical alprazolam useSubscription

The benzodiazepine alprazolam is being obtained for non-medical use in the UK, particularly among young people, a survey has found.

Glucose test for diabetes

Immunotherapy delays type 1 diabetes mellitus in high-risk individualsSubscription

Certain individuals at high risk of developing type 1 diabetes mellitis can delay progression to clinical disease by two years or more with a two-week course of teplizumab, according to a phase II study Source: Shutterstock.com

Vitamin D fish oil supplement

Vitamin D not protective against cardiovascular eventsSubscription

Vitamin D supplementation is not associated with a reduced risk of major cardiovascular events, a meta-analysis suggests.

More research briefings

Barrett’s Mandrake Embrocation (ca. 1885-1907)

Barrett’s Mandrake Embrocation (ca. 1885–1907)

Who says the Victorians didn’t have a sense of humour?

Pharm2U robot

Inside Pharmacy2USubscription

From controversial marketing campaigns to fears that its vast dispensing facilities will quash high street pharmacy businesses, Pharmacy2U’s rise has not gone unnoticed.

More features

Promacedonia opioid infographic

Opioids in England: crisis averted? Subscription

Despite a 20% increase in opioid prescriptions per 1,000 population over the past decade, there are signs that a US-style opioid epidemic may have been averted.

More infographics

цена на горох


Миксеры планетарные